Figure 6E shows a positive control from human colon carcinoma and ovarian carcinoma with cytoplasmic immunoreactivity (Figure 6E, left and middle) and a negative control which had the primary CIP2A antibody replaced by PBS (Figure 6E, right). This evidence concerns the gene CIP2A and colon carcinoma.